Page 23 - 82_03
P. 23
M.ª del Carmen Avendaño López
Anti-ganglioside Specificities. ACS Chem Biol 2013;
8: 376-86.
58. Agostino M, Yuriev E, Ramsland PA. Antibody
Recognition of Cancer-Related Gangliosides and
Their Mimics Investigated Using in silico Site
Mapping. PLoS ONE 2012; 7: e35457.
59. Krengel U, Olsson L-L, Martínez C, Talavera A, et al.
Structure and Molecular Interactions of a Unique
Antitumor Antibody Specific for N-Glycolyl GM3. J
Biol Chem 2004; 279: 5597-5603.
60. Avendaño C, Menéndez JC. Biological Therapy of
Cancer. In: Medicinal Chemistry of Anticancer Drugs.
Amsterdam (Netherlands), Elsevier 2015: pp . 577-79.
61. Taylor RE, Padler-Karavani V, Diaz S, Varki A.
Implications of the presence of N-glycolylneuraminic
acid in recombinant therapeutic glycoproteins. Nat
Biotechnol 2010; 28: 863-67.
62. Martín MJ, Muotri A, Gage F, Vaki A. Human
embryonic cells express an immunogenic nonhuman
sialic acid. Nature Med 2005; 11: 228-32.
282 @Real Academia Nacional de Farmacia. Spain
